Post Op Setting News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A panel deliberates post-neoadjuvant strategies and data requirements for optimizing immune checkpoint inhibitors in NSCLC neoadjuvant therapy.

David carboneMartin dietrichPatrick fordeNon small cell lung cancerAdvanced diseaseEarly stage diseasePost op settingNovel agentTargeted therapyTrio therapy